Akeso, Inc. (AKESF)
10.61
+0.11
(+1.01%)
USD |
OTCM |
Oct 28, 16:00
Akeso Price : 10.61 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 10.30 | 10.61 | 10.30 | 10.61 | 717.00 |
| Oct 27, 2026 | 10.50 | 10.50 | 10.50 | 10.50 | 1020.00 |
| Oct 26, 2026 | 10.75 | 10.75 | 10.75 | 10.75 | 1029.00 |
| Oct 23, 2026 | 10.72 | 10.85 | 10.72 | 10.85 | 1000.00 |
| Oct 22, 2026 | 11.00 | 11.10 | 10.58 | 10.84 | 1710.00 |
| Oct 21, 2026 | 12.14 | 12.14 | 12.14 | 12.14 | 0.000 |
| Oct 20, 2026 | 11.58 | 12.14 | 11.58 | 12.14 | 1160.00 |
| Oct 19, 2026 | 11.75 | 12.00 | 11.48 | 11.48 | 1835.00 |
| Oct 16, 2026 | 11.25 | 11.25 | 11.25 | 11.25 | 15.00 |
| Oct 15, 2026 | 11.25 | 11.25 | 11.25 | 11.25 | 14050.00 |
| Oct 14, 2026 | 12.50 | 12.50 | 12.00 | 12.00 | 1597.00 |
| Oct 13, 2026 | 13.25 | 13.25 | 13.15 | 13.15 | 200.00 |
| Oct 12, 2026 | 14.54 | 14.54 | 14.54 | 14.54 | 0.000 |
| Oct 09, 2026 | 14.50 | 14.54 | 14.50 | 14.54 | 1550.00 |
| Oct 08, 2026 | 13.80 | 13.80 | 13.80 | 13.80 | 0.000 |
| Oct 07, 2026 | 13.85 | 13.85 | 13.80 | 13.80 | 14200.00 |
| Oct 06, 2026 | 13.75 | 13.75 | 13.75 | 13.75 | 25.00 |
| Oct 05, 2026 | 13.75 | 13.75 | 13.75 | 13.75 | 100.00 |
| Oct 02, 2026 | 13.55 | 13.55 | 13.44 | 13.44 | 2105.00 |
| Oct 01, 2026 | 13.56 | 13.56 | 13.56 | 13.56 | 201.00 |
| Sep 30, 2026 | 13.75 | 13.75 | 13.28 | 13.28 | 3850.00 |
| Sep 29, 2026 | 13.30 | 13.30 | 13.00 | 13.00 | 10715.00 |
| Sep 28, 2026 | 12.60 | 12.60 | 12.60 | 12.60 | 83.00 |
| Sep 25, 2026 | 12.60 | 12.60 | 12.60 | 12.60 | 100.00 |
| Sep 24, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 1013.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.72 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 2.68 |
Price Related Metrics
| PS Ratio | 19.64 |
| PEG Ratio | -2.833 |
| Price to Book Value | 156.80 |
| Earnings Yield | -1.42% |
| Market Cap | 9.743B |
| PEGY Ratio | -2.833 |